83 related articles for article (PubMed ID: 9846435)
1. [The vasoconstrictor effect of cyclosporine on the pulmonary vein is mediated by its vehicle: the cremophor].
Mathieu P; Demers P; Elkouri S; Cartier R
Ann Chir; 1998; 52(8):821-6. PubMed ID: 9846435
[TBL] [Abstract][Full Text] [Related]
2. [Effect of cyclosporin A on the reactivity of the pulmonary vascular network in dogs].
Mathieu P; Cartier R; Carrier M; Pelletier LC
Ann Chir; 1996; 50(8):682-8. PubMed ID: 9035443
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine-induced coronary artery constriction--dissociation between thromboxane release and coronary vasospasm.
Braun-Dullaeus RC; Feussner M; Walker G; Hopmann H; Kraemer HJ; Grimminger F; Tillmanns H; Haberbosch W
J Heart Lung Transplant; 1999 Apr; 18(4):328-35. PubMed ID: 10226897
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine A preparations and their vehicles induce contraction of the guinea pig gallbladder in vitro: the role of cyclooxygenase metabolites.
Yasar U; Erdem SR; Tuncer M
Pharmacology; 1999 Jun; 58(6):309-18. PubMed ID: 10325576
[TBL] [Abstract][Full Text] [Related]
5. [Effects of cyclosporine A on the reactivity of the aorta with regenerated endothelium in rats].
Dagenais F; Hollmann C; Buluran J; Cartier R
Ann Chir; 1995; 49(8):694-9. PubMed ID: 8561423
[TBL] [Abstract][Full Text] [Related]
6. Direct vascular smooth muscle contractile effect of cyclosporin A and its vehicle in rabbit isolated arteries.
Yariş E; Tuncer M; Kayaalp SO; Ilhan M
Arch Int Pharmacodyn Ther; 1994; 327(2):166-74. PubMed ID: 7979825
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine A and cremophor EL induce contractions of human saphenous vein: involvement of thromboxane A2 receptor-dependent pathway.
Hardy G; Stanke-Labesque F; Deveaux G; Devillier P; Sessa C; Bessard G
J Cardiovasc Pharmacol; 2000 Dec; 36(6):693-8. PubMed ID: 11117367
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute rejection and antirejection therapy on arteries and veins from canine single lung allografts.
Aarnio P; Scherstén H; Tazelaar HD; Miller VM; McGregor CG
J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1219-29. PubMed ID: 8642824
[TBL] [Abstract][Full Text] [Related]
9. [Effect of cyclosporin A dosage on the vascular tone of the thoracic aorta of rats].
Cartier R; Mathieu P; Bouchard D; Buluran J
Ann Chir; 1996; 50(8):667-72. PubMed ID: 9035441
[TBL] [Abstract][Full Text] [Related]
10. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
Bouchard D; Despatis MA; Buluran J; Cartier R
Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698
[TBL] [Abstract][Full Text] [Related]
11. Role of thromboxane and angiotensin in cyclosporine-induced renal vasoconstriction in the dog.
Carrier M; Tronc F; Pelletier LC; Latour JG
J Heart Lung Transplant; 1993; 12(5):851-5. PubMed ID: 8241227
[TBL] [Abstract][Full Text] [Related]
12. [Effect of pentoxifylline on the vascular toxicity secondary to cyclosporine in rats].
Latulippe JF; Buluran J; Cartier R
Ann Chir; 1995; 49(8):712-8. PubMed ID: 8561426
[TBL] [Abstract][Full Text] [Related]
13. Direct vasoconstrictor effects of sandimmune (cyclosporine A) are mediated by its vehicle cremophor EL: inhibition by the thromboxane A2/prostaglandin endoperoxide receptor antagonist ifetroban.
Lodge NJ
J Pharmacol Exp Ther; 1994 Nov; 271(2):730-4. PubMed ID: 7965789
[TBL] [Abstract][Full Text] [Related]
14. Slow channel calcium blockers attenuate reoxygenation-mediated vascular contraction, but augment anoxia-mediated vascular contraction.
Haught WH; Yang BC; Lawson DL; Mehta JL
J Cardiovasc Pharmacol; 1992 May; 19(5):701-8. PubMed ID: 1381767
[TBL] [Abstract][Full Text] [Related]
15. Effect of heartworm infection on in vitro contractile responses of canine pulmonary artery and vein.
Maksimowich DS; Mupanomunda M; Williams JF; Kaiser L
Am J Vet Res; 1997 Apr; 58(4):395-7. PubMed ID: 9099386
[TBL] [Abstract][Full Text] [Related]
16. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms Involved in Thromboxane A
Grann M; Comerma-Steffensen S; Arcanjo DD; Simonsen U
Basic Clin Pharmacol Toxicol; 2016 Oct; 119 Suppl 3():86-95. PubMed ID: 26708952
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
[TBL] [Abstract][Full Text] [Related]
19. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.
Mosseri M; Fingert HJ; Varticovski L; Chokshi S; Isner JM
Cancer Res; 1993 Jul; 53(13):3028-33. PubMed ID: 8391384
[TBL] [Abstract][Full Text] [Related]
20. Preventive effects of diltiazem on cyclosporin A-induced vascular smooth muscle dysfunction.
Götze S; Auch-Schwelk W; Bossaller C; Thelen J; Fleck E
Transpl Int; 1994 May; 7(3):157-62. PubMed ID: 8060463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
